Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Rating of "Buy" from Analysts

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been assigned a consensus rating of "Buy" from the ten ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have given a buy rating and two have issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $132.78.

Several research firms have issued reports on ADUS. JMP Securities began coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price objective on the stock. Stephens reaffirmed an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, Macquarie reissued an "outperform" rating and issued a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th.

Remove Ads

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 4.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP acquired a new stake in shares of Addus HomeCare during the third quarter valued at about $28,000. Natixis increased its position in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Addus HomeCare during the fourth quarter valued at about $77,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

NASDAQ ADUS traded down $0.34 during mid-day trading on Monday, reaching $90.90. 156,330 shares of the stock were exchanged, compared to its average volume of 147,263. The business's 50 day moving average is $113.25 and its 200-day moving average is $122.39. Addus HomeCare has a 1 year low of $87.88 and a 1 year high of $136.72. The company has a market capitalization of $1.65 billion, a P/E ratio of 20.80, a P/E/G ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.